3,065
Views
45
CrossRef citations to date
0
Altmetric
Original Research

A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo

, ORCID Icon, , , , , , , & ORCID Icon show all
Article: e1408746 | Received 25 Aug 2017, Accepted 18 Nov 2017, Published online: 06 Dec 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Tobias Achu Muluh, Zhuo Chen, Yi Li, Kang Xiong, Jing Jin, ShaoZhi Fu & JingBo Wu. (2021) Enhancing Cancer Immunotherapy Treatment Goals by Using Nanoparticle Delivery System. International Journal of Nanomedicine 16, pages 2389-2404.
Read now
Mohammad Zaki Ahmad, Javed Ahmad, Anzarul Haque, Mohammed Yahia Alasmary, Basel A. Abdel-Wahab & Sohail Akhter. (2020) Emerging advances in synthetic cancer nano-vaccines: opportunities and challenges. Expert Review of Vaccines 19:11, pages 1053-1071.
Read now
Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, Sabine Tejpar, Peter Vandenberghe, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2020) Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. OncoImmunology 9:1.
Read now
Gaetano Donofrio, Giulia Tebaldi, Stefania Lanzardo, Roberto Ruiu, Elisabetta Bolli, Andrea Ballatore, Valeria Rolih, Francesca Macchi, Laura Conti & Federica Cavallo. (2018) Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells. OncoImmunology 7:12.
Read now

Articles from other publishers (41)

Ravinder Verma, Shailendra Bhatt, Rohit Dutt, Manish Kumar, Deepak Kaushik & Rupesh K. Gautam. 2023. Drug and Therapy Development for Triple Negative Breast Cancer. Drug and Therapy Development for Triple Negative Breast Cancer 153 180 .
Krishna Mahanti & Sankar Bhattacharyya. (2023) Rough neighborhood: Intricacies of cancer stem cells and infiltrating immune cell interaction in tumor microenvironment and potential in therapeutic targeting.. Translational Research.
Crossref
Lyudmila V. Bel’skaya, Ivan A. Gundyrev & Denis V. Solomatin. (2023) The Role of Amino Acids in the Diagnosis, Risk Assessment, and Treatment of Breast Cancer: A Review. Current Issues in Molecular Biology 45:9, pages 7513-7537.
Crossref
Francesca Ruzzi, Maria Sofia Semprini, Laura Scalambra, Arianna Palladini, Stefania Angelicola, Chiara Cappello, Olga Maria Pittino, Patrizia Nanni & Pier-Luigi Lollini. (2023) Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy. International Journal of Molecular Sciences 24:16, pages 12963.
Crossref
Raphael P. Viscidi, Treva Rowley & Ioannis Bossis. (2023) Bioengineered Bovine Papillomavirus L1 Protein Virus-like Particle (VLP) Vaccines for Enhanced Induction of CD8 T Cell Responses through Cross-Priming. International Journal of Molecular Sciences 24:12, pages 9851.
Crossref
Weixun Peng. (2023) Roles of Virus-like particles in particularcancer vaccines. Highlights in Science, Engineering and Technology 36, pages 1517-1524.
Crossref
Enza Di Gregorio, Chiara Romiti, Antonino Di Lorenzo, Federica Cavallo, Giuseppe Ferrauto & Laura Conti. (2022) RGD_PLGA Nanoparticles with Docetaxel: A Route for Improving Drug Efficiency and Reducing Toxicity in Breast Cancer Treatment. Cancers 15:1, pages 8.
Crossref
Atefeh Arab, Amin Reza Nikpoor, Peyman Asadi, Reza Iraei, Rezvan Yazdian-Robati, Afsana Sheikh & Prashant Kesharwani. (2022) Virus-like nanoparticles (VLPs) based technology in the development of breast cancer ‎vaccines‎. Process Biochemistry 123, pages 44-51.
Crossref
Giuseppina Barutello, Antonino Di Lorenzo, Alessandro Gasparetto, Chiara Galiazzi, Elisabetta Bolli, Laura Conti & Federica Cavallo. (2022) Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models. Biomedicines 10:11, pages 2843.
Crossref
Xiao Yin Ma, Brett D. Hill, Trang Hoang & Fei Wen. (2022) Virus-inspired strategies for cancer therapy. Seminars in Cancer Biology 86, pages 1143-1157.
Crossref
Linlin Sheng, Qi Luo & Ligong Chen. (2022) Amino Acid Solute Carrier Transporters in Inflammation and Autoimmunity. Drug Metabolism and Disposition 50:9, pages 1228-1237.
Crossref
Fatemeh Davodabadi, Mohammad Sarhadi, Javad Arabpour, Saman Sargazi, Abbas Rahdar & Ana M. Díez-Pascual. (2022) Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches. Journal of Controlled Release 349, pages 844-875.
Crossref
Feng-Jiao Li, Hui-Zhi Long, Zi-Wei Zhou, Hong-Yu Luo, Shuo-Guo Xu & Li-Chen Gao. (2022) System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Frontiers in Pharmacology 13.
Crossref
Sijia Li, Zhenyao Lu, Runbin Sun, Suhan Guo, Fangfang Gao, Bei Cao & Jiye Aa. (2022) The Role of SLC7A11 in Cancer: Friend or Foe?. Cancers 14:13, pages 3059.
Crossref
Thomas G. W. Edwardson, Mikail D. Levasseur, Stephan Tetter, Angela Steinauer, Mao Hori & Donald Hilvert. (2022) Protein Cages: From Fundamentals to Advanced Applications. Chemical Reviews 122:9, pages 9145-9197.
Crossref
Qi Zhang & Wei Li. (2022) Correlation between amino acid metabolism and self-renewal of cancer stem cells: Perspectives in cancer therapy. World Journal of Stem Cells 14:4, pages 267-286.
Crossref
Roberto Ruiu, Antonino Di Lorenzo, Federica Cavallo & Laura Conti. (2022) Are Cancer Stem Cells a Suitable Target for Breast Cancer Immunotherapy?. Frontiers in Oncology 12.
Crossref
Shiyao Sui, Shouping Xu & Da Pang. (2022) Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression. Pharmacology & Therapeutics 232, pages 107992.
Crossref
Soledad Palameta, Andrea J. Manrique-Rincón, Jessica M. Toscaro, Isadora F. Semionatto, Matheus C. Fonseca, Rhubia S.M. Rosa, Luciana P. Ruas, Paulo S.L. Oliveira & Marcio C. Bajgelman. (2022) Boosting antitumor response with PSMA-targeted immunomodulatory VLPs, harboring costimulatory TNFSF ligands and GM-CSF cytokine. Molecular Therapy - Oncolytics 24, pages 650-662.
Crossref
Alba Navarro-Ocón, Jose L. Blaya-Cánovas, Araceli López-Tejada, Isabel Blancas, Rosario M. Sánchez-Martín, María J. Garrido, Carmen Griñán-Lisón, Jesús Calahorra, Francisca E. Cara, Francisco Ruiz-Cabello, Juan A. Marchal, Natalia Aptsiauri & Sergio Granados-Principal. (2022) Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer. Pharmaceutics 14:3, pages 505.
Crossref
Nidhi Jyotsana, Kenny T. Ta & Kathleen E. DelGiorno. (2022) The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer. Frontiers in Oncology 12.
Crossref
Ekaitz Errasti-Murugarren & Manuel Palacín. (2021) Heteromeric Amino Acid Transporters in Brain: from Physiology to Pathology. Neurochemical Research 47:1, pages 23-36.
Crossref
Xihui Gao, Junqiang Ding, Qianqian Long & Changyou Zhan. (2020) Virus‐mimetic systems for cancer diagnosis and therapy. WIREs Nanomedicine and Nanobiotechnology 13:3.
Crossref
Vincenzo Salemme, Giorgia Centonze, Federica Cavallo, Paola Defilippi & Laura Conti. (2021) The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy. Frontiers in Oncology 11.
Crossref
Saghi Nooraei, Howra Bahrulolum, Zakieh Sadat Hoseini, Camellia Katalani, Abbas Hajizade, Andrew J. Easton & Gholamreza Ahmadian. (2021) Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers. Journal of Nanobiotechnology 19:1.
Crossref
Jolanda Magri, Alessandro Gasparetto, Laura Conti, Enzo Calautti, Chiara Cossu, Roberto Ruiu, Giuseppina Barutello & Federica Cavallo. (2021) Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies. Cells 10:1, pages 108.
Crossref
Ajay Kumar Pal, Mukesh Nandave & Rupesh K. Gautam. 2021. Advanced Drug Delivery Systems in the Management of Cancer. Advanced Drug Delivery Systems in the Management of Cancer 387 407 .
Antonino Di Lorenzo, Elisabetta Bolli, Lidia Tarone, Federica Cavallo & Laura Conti. (2020) Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota. International Journal of Molecular Sciences 21:24, pages 9418.
Crossref
Zhaoqing Li, Lini Chen, Cong Chen, Yulu Zhou, Dengdi Hu, Jingjing Yang, Yongxia Chen, Wenying Zhuo, Misha Mao, Xun Zhang, Ling Xu, Linbo Wang & Jichun Zhou. (2020) Targeting ferroptosis in breast cancer. Biomarker Research 8:1.
Crossref
Keman Cheng, Qinglin Kang & Xiao Zhao. (2020) Biogenic nanoparticles as immunomodulator for tumor treatment. WIREs Nanomedicine and Nanobiotechnology 12:6.
Crossref
Laura Conti, Elisabetta Bolli, Antonino Di Lorenzo, Valentina Franceschi, Francesca Macchi, Federica Riccardo, Roberto Ruiu, Luca Russo, Elena Quaglino, Gaetano Donofrio & Federica Cavallo. (2020) Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer. Cancer Immunology Research 8:8, pages 1039-1053.
Crossref
Aubrey M. Demchuk & Trushar R. Patel. (2020) The biomedical and bioengineering potential of protein nanocompartments. Biotechnology Advances 41, pages 107547.
Crossref
Valeria Rolih, Jerri Caldeira, Elisabetta Bolli, Ahmad Salameh, Laura Conti, Giuseppina Barutello, Federica Riccardo, Jolanda Magri, Alessia Lamolinara, Karla Parra, Paloma Valenzuela, Giulio Francia, Manuela Iezzi, Federica Pericle & Federica Cavallo. (2020) Development of a VLP-Based Vaccine Displaying an xCT Extracellular Domain for the Treatment of Metastatic Breast Cancer. Cancers 12:6, pages 1492.
Crossref
Nils Hillebrandt, Philipp Vormittag, Nicolai Bluthardt, Annabelle Dietrich & Jürgen Hubbuch. (2020) Integrated Process for Capture and Purification of Virus-Like Particles: Enhancing Process Performance by Cross-Flow Filtration. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Jerri C. Caldeira, Michael Perrine, Federica Pericle & Federica Cavallo. (2020) Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines. Viruses 12:5, pages 488.
Crossref
Elena Quaglino, Laura Conti & Federica Cavallo. (2020) Breast cancer stem cell antigens as targets for immunotherapy. Seminars in Immunology 47, pages 101386.
Crossref
Mona O. Mohsen, Daniel E. Speiser, Alexander Knuth & Martin F. Bachmann. (2019) Virus‐like particles for vaccination against cancer. WIREs Nanomedicine and Nanobiotechnology 12:1.
Crossref
Hermann AM Mucke. (2019) Patent highlights October–November 2018. Pharmaceutical Patent Analyst 8:2, pages 43-50.
Crossref
Roberto Ruiu, Valeria Rolih, Elisabetta Bolli, Giuseppina Barutello, Federica Riccardo, Elena Quaglino, Irene Fiore Merighi, Federica Pericle, Gaetano Donofrio, Federica Cavallo & Laura Conti. (2018) Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter. Cancer Immunology, Immunotherapy 68:1, pages 131-141.
Crossref
Adil Allahverdiyev, Gamze TariMelahat BagirovaEmrah Sefik Abamor. (2018) Current Approaches in Development of Immunotherapeutic Vaccines for Breast Cancer. Journal of Breast Cancer 21:4, pages 343.
Crossref
C. Tilden HaganIVIV, Yusra B. Medik & Andrew Z. Wang. 2018. Cancer Nanotechnology. Cancer Nanotechnology 35 56 .